A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram-Negative Ventilator-Associated Pneumonia
Marin H. Kollef(Washington University in St. Louis), A. Bruce Montgomery, Denis Garot(Centre Hospitalier Universitaire de Tours), Wayne Danker(Research Triangle Park Foundation), Zsolt Rozgonyi(Országos Korányi Tbc és Pulmonológiai Intézet), Jean-Damien Ricard(Inserm), Firas Koura, George Dimοpoulos(National and Kapodistrian University of Athens), Eleni Ischaki(National and Kapodistrian University of Athens), Damien Roux(Inserm), Antoní Torres(Centro de Investigación Biomédica en Red de Enfermedades Respiratorias), Bruno François(Inserm), János Gál(Semmelweis University), Thierry Boulain(Centre hospitalier universitaire d'Orléans), Zsolt Iványi(Semmelweis University), Epaminondas Zakynthinos(Unknown)
Cited by 174
Related Papers
High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure
|New England Journal of Medicine|2015|2.4k
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
|European Respiratory Journal|2017|1.4k
Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database
|CHEST Journal|2002|1.3k
Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit
|The Lancet Respiratory Medicine|2014|1.3k
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
|Intensive Care Medicine|2020|1.1k